Postponement Annual Shareholders Meeting - Amendment financial calendar
05 Avril 2024 - 2:00PM
Postponement Annual Shareholders Meeting
- Amendment financial calendarLeuven, BELGIUM –
April 5, 2024 – 02:00 PM CET Oxurion NV (Euronext
Brussels: OXUR), a biopharmaceutical company headquartered in
Leuven, today made the following announcement regarding its
financial calendar.
Due to administrative reasons, the annual accounts of the
Company have not been finalized yet. Hence, the Company has decided
to postpone its Annual Shareholders Meeting to Thursday May 16,
2024.
The financial calendar on the Company website has been updated
accordingly.
About Oxurion
Oxurion (Euronext Brussels: OXUR) is engaged in
developing next-generation standard of care ophthalmic therapies
for the treatment of retinal disease. Oxurion is based in Leuven,
Belgium. More information is available at www.oxurion.com.
Please contact for additional information:
|
Oxurion NVPascal GhosonChief Executive
Officerpascal.ghoson@oxurion.com |
Backstage CommunicationJurgen
VluijmansPartnerjurgen@backstagecom.be |
Oxurion NV (EU:OXUR)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Oxurion NV (EU:OXUR)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
